Continuing obligations/periodic reporting
Continuing obligations/periodic reporting

[Last updated: 1 January 2024, unless otherwise noted]

Continuing listing obligations

Subsequent to the listing, a listed company is required to provide continuing disclosures to the PSE. The corporate disclosures are classified into two reports: structured and unstructured reports. Structured reports refer to standard reporting requirements needed to be submitted within specific timeframes, such as:

  • Annual report, to be filed within 105 days of the end of the fiscal year.
  • Quarterly reports, to be filed within 45 days from the end of the respective first three quarters of the fiscal year.
  • Other periodic reports, which may be prescribed by the regulatory bodies.

Unstructured continuing disclosure requirements refer to the requirement for a listed company to update the investing public with any material fact or event that occurs, which would reasonably be expected to affect investors' decisions in relation to the trading of its securities.

A material fact or event is one which would reasonably be expected to affect investors' decisions in relation to those securities. This includes, but is not limited to, any significant and relevant information relating to the business and operations of the listed company that if disclosed would reasonably be expected to cause a significant change in the market value of the securities.

Material information should be reported within 10 minutes from the receipt of such information or the happening or occurrence of said act, development, or event. Disclosure should first be made to the PSE prior to release to the media.

There are certain events, the occurrence of which mandate prompt disclosure to the PSE. These events include, among others:

  • Change in control of the Issuer of securities.
  • Any declaration of cash dividend, share dividend, and pre-emptive rights of the Board of Directors.
  • Any change in the Issuer's fiscal year and the reason(s) thereof.
  • Filing of any legal proceeding by or against the issuer and/or its subsidiaries involving a claim amounting to 10% or more of the issuer's total current assets or any legal proceeding against its President and or member of the Board of Directors in their capacity as such.
  • Merger, consolidation, or spin-off of the Issuer.
  • A new product or discovery.
  • Purchase or sale of significant assets amounting to 10% or more of the Issuer's total assets, which is not in the ordinary course of business.
  • Loss or potential losses, the aggregate of which amounts to at least 10% of the consolidated total assets of the Issuer.
  • Default of financing or sale agreements.
  • Borrowing of significant amount of funds not in the ordinary course of business.
  • Any delay in the payment of debentures, negotiable obligations, bonds, or other publicly traded security.